IRCT20200927048849N2已完成2 期
Comparison of the Effectiveness of COVID-19 specific antibody in hyperimmune bovine milk & colostrum with ordinary bovine milk & colostrum in improving clinical symptoms and laboratory parameters and outcomes of patients with COVID-19 admitted to Hospital
Isfahan university0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Infected patients of COVID-19 based on positive PCR or HRCT result compatible with disease
- •Hospitalization of patient in hospital
- •With oxygen via nasal cannula
- •93%=O2 Sat
- •Age >18years old
- •Filling and signing of consent form
- •Allowing the patient to consume food orally
排除标准
- •Patients with immunodeficiency based on biography
- •Patients with Lactose intolerance based on biography
- •Uncontrollable vomit
研究者
相似试验
招募中
3 期
Effect of hyperimmune bovine milk & colostrum in the healing process of COVID-19 patientsIRCT20200927048849N3Isfahan university600
终止
不适用
Effectiveness of the Fiocruz Vaccine ® against different variants of SARS-COV-2 in Botucatu-SPRBR-8yrrf9sniversidade Estadual Paulista Júlio de Mesquita Filho (UNESP) - Faculdade de Medicina de Botucatu (FMB)
尚未招募
不适用
Effect of recombinant erythropoietin in covid-19 patients.CTRI/2020/11/028959All India Institute Of Medical Sciences New Delhi
已完成
Unknown
Clinical Performance Verification Study of "COVID-19 Ag Rapid Saliva Test Device" for Diagnostic Aid of SARS-CoV-2 InfectioCOVID-19JPRN-UMIN000049723BIC GROUP Ltd.120
招募中
3 期
The impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan AfricaAncillary Study of the ANTICOV Study:An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19Covid-19PACTR202010781639956DNDi1,000